One position as ESR-Early Stage Researcher (PhD student) in the field of Immunotherapy of Cancer

Institut Gustave Roussy
October 12 2017
Position Type
Full Time
Organization Type

One position as ESR-Early Stage Researcher (PhD student) in the field of Immunotherapy of Cancer

Description: IMMUTRAIN is a research network funded by the Marie Skłodowska-Curie Actions. It comprises nine academic research groups and five industrial partners in nine European countries. The joint goal is to train the next generation of scientists in the field of immunotherapy of cancer. The research objective of IMMUTRAIN is to enhance the efficacy of antibody-based tumor therapies through combination with other immunotherapeutic approaches. Please find further information at

We offer: Cutting edge research projects and training with leading experts in the field of immunotherapy of cancer; employment contract for a maximum of two years with the benefits of the EU Marie Skłodowska-Curie programme; opportunities for future employment.

We seek: Excellent scientists with a master degree or equivalent in natural sciences or related disciplines (such as medicine or pharmacy); practical skills in modern laboratory work, preferentially combined with experience in animal experiments.

Your profile: You must be within your first four years of research experience after completion of your masters degree or equivalent; you cannot hold a doctoral degree at the time of recruitment; you cannot have spent more than 12 months within the past 36 months in France (mobility rule); you must be proficient in the English language both written and spoken (proof required).

Open position:

ESR11 at Institut Gustave Roussy, France for a project within the work package 4, “Target discovery and validation for antibody combination therapies”.


The application procedure will be carried out in compliance with the Code of Conduct for Recruitment and the Charter for Researchers. Please send your application until November 19th 2017 to: We look forward to your application.

This job comes from a partnership with Science Magazine and Euraxess